Pingora Partners LLC purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, Holdings Channel.com reports. The firm purchased 1,450 shares of the company’s stock, valued at approximately $225,000. Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. […]
Relative Value Partners Group LLC trimmed its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,462 shares of the company’s stock after selling 128 shares during the period. Relative Value […]
Gold Investment Management Ltd. bought a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 12,953 shares of the company’s stock, valued at approximately $2,007,000. A number of other institutional investors and hedge […]
Qtron Investments LLC lifted its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,574 shares of the company’s stock after buying an additional 650 shares during the period. Qtron Investments LLC’s holdings […]
Oliver Luxxe Assets LLC lifted its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 37,445 shares of the company’s stock after acquiring an additional 224 shares during the quarter. AbbVie accounts for 1.4% […]